ABL Diagnostics lifts 2026 revenue outlook to EUR 13.5 million-EUR 14 million
Bitget2026/10/01 16:01- ABL Diagnostics lifted its 2026 revenue outlook to EUR 13.5 million to EUR 14 million from EUR 12.265 million.
- The new range implies 94.2% to 101.4% growth from 2025 revenue of EUR 6.95 million.
- First-half revenue reached EUR 5.415 million, up 90% year over year, with EBITDA of EUR 1.315 million.
- Guidance revision factors in second-half momentum, with TEXCELL activities contributing following the July 21 takeover.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
ICE brings futures trading to London’s $190 billion-a-day physical gold market
Precia reports 5,733,040 issued shares, 8,350,574 exercisable voting rights as of Aug. 31, 2026
Precia disclosed 5,733,040 issued shares as of Aug. 31, 2026. Theoretical voting rights totaled 8,677,204. Exercisable voting rights stood at 8,350,574, reflecting 326,630 treasury shares without voting rights. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Precia SA published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.
Asia FX: Tech-linked FX could outperform against US Dollar - MUFG
Sumitomo Metal expects global nickel market to stay in surplus in 2027
Crypto prices
More
